Treatment modalities of diabetes mellitus and outcomes of acute coronary syndromes

Coronary Artery Disease

Volumn 15, Issue 3, 2004, Pages 129-135

  Hasdai, David ^a   Behar, Solomon ^b   Boyko, Valentina ^b   Battler, Alexander ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute coronary syndromes; Diabetes mellitus; Insulin; Metformin; Oral hypoglycaemics; Sulfonylureas

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ACUTE DISEASE; ADULT; AGED; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CORONARY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; ELECTROCARDIOGRAPHY; EUROPE; FEMALE; HEALTH SURVEYS; HOSPITAL MORTALITY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); REGISTRIES; SYNDROME;

EID: 2342524610     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200405000-00001     Document Type: Review

References (28)

1. Barbash GI, White HD, Modan M, Van de Werf F. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol 1993; 22:707-713.
2. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126:296-306.
3. Gray RP, Yudkin JS, Patterson DL. Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor? Br Heart J 1993; 70:530-536.
4. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994; 43:104-109.
5. Lynch M, Gannage MD, Lamb P, Nattrass M, Pentecost BL. Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabetic Med 1994; 11:162-166.
6. Jelesoff NE, Feinglos M, Granger CB, Califf RM. Outcomes of diabetic patients following acute myocardial infarction: a review of the major thromborytic trials. Coron Artery Dis 1996; 7:732-743.
7. Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol 1997; 30:171-179.
8. Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996; 28:1661-1669.
9. Lomuscio A, Castagnone M, Vergani D, Verzoni A, Bertrani A, Ravaglia R, et al. Clinical correlates between diabetic and non-diabetic patients with myocardial infarction. Acta Cardiol 1991; 48:543-554.
10. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb R, Lewis SM. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 1988; 62:665-669.
11. Bell DSH. Diabetes mellitus and coronary disease. Coron Artery Dis 1996; 7:716-722.
12. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, et al. The effects of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary artery disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989; 14:49-57.
13. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thromborytic agents. The Thrombolysis and Angioplasty in Myocardial infarction (TAMI) Study Group. J Am Coll Cardiol 1993; 21:920-025.
14. Abboud ZA, Shindler DM, Wilson AC, Koetis JB. Effect of diabetes mellitus on short and long term mortality rates of patients with acute myocardial infarction: a statewide study. Am Heart J 1995; 130:51-58.
15. Singer DE, Moulton AW, Nathan DM. Diabetic myocardial infarction: interaction of diabetes with other pre-infarction risk factors. Diabetes 1989; 38:350-357.
16. Hasdai D, Granger CB, Srivatsa SS, Criger DA, Ellis SG, Califf RM, et al. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. J Am Coll Cardiol 2000; 36:1502-1512.
17. Behar S, Boyko V, Reicher-Reiss H, Goldbourt U, for the SPRINT Study Group. Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. Am Heart J 1997; 133:290-296.
18. Malmberg K, Yusuf S, Gerstain HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry. Circulation 2000; 102:1014-1019.
19. Brady PA, Terzic A. The sulfonylurea controversy, more questions from the heart. J Am Coll Cardiol 1998; 31:350-956.
20. Klimt C, Knatterud GL, Meinert CL, Prout TE. A study of the effects of hypoglycaemic agents in vascular complications in patients with adult-onset diabetes. Diabetes 1970; 19:747-830.
21. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999; 33:119-124.
22. Zangeneh F, Kudva YC, Basu A. Insulin sensitizers. Mayo Clin Proc 2003; 78:471-479.
23. Fisman EZ, Tenebaum A, Benderly M, Goldbourt U, Behar S, Motro M. Antihyperglycaemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a five-year folow-up. Cardiology 1999; 91:195-202.
24. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin: the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23:1190-1201.
25. Lev EI, Battler A, Behar S, Porter A, Haim M, Boyko V, et al. Frequency, characteristics and outcome of acute coronary syndrome patients admitted with undetermined ECG. Am J Cardiol 2003; 91:224-227
26. Malmberg K. Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997; 31:1512-1515.
27. Hasdai D, Rizza RA, Holmes DR Jr, Richardson DM, Cohen P, Lerman A. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension 1998; 32:228-234.
28. Hasdai D, Rizza RA, Grill DE, Scott CG, Garratt KN, Holmes DR Jr. Treatment of diabetes mellitus by diet alone versus oral hypoglycaemics versus insulin and outcome after successful percutaneous coronary revascularisation. Heart Drug 2001; 1:138-143.